SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950133-06-000729
Filing Date
2006-02-14
Accepted
2006-02-14 14:41:34
Documents
2
Group Members
VENROCK ASSOCIATES III, L.P.VENROCK ENTREPRENEURS FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G w17560dsc13g.htm SC 13G 71145
2 EXHIBIT 99.1 w17560dexv99w1.htm EX-99.1 4612
  Complete submission text file 0000950133-06-000729.txt   77810
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

IRS No.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address C/O JAMES CHICOSKI; MINTZ, LEVIN, ET AL ONE FINANCIAL CENTER BOSTON MA 02111
Business Address 93 WORCESTER ST. SUITE 101 WELLESLEY MA 02481 617-348-1738
Coley Pharmaceutical Group, Inc. (Subject) CIK: 0001319197 (see all company filings)

IRS No.: 061506689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81303 | Film No.: 06613112
SIC: 2834 Pharmaceutical Preparations